- Research works
- 61 ▲ 130% vs 2018-21
- Citations
- 892 14.6 per fractional work
- Top-10% rate
- 15.3% all institutions 10.0%
- Open access
- 53% world 40%
- International
- 56% world 18%
Not ranked overall: MedSIR (Spain) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does MedSIR (Spain) work in?
In 2022-now, 73% of research at MedSIR (Spain) is in Health Sciences, 14% in Life Sciences. Its largest fields are Medicine (73%), Biochemistry, Genetics and Molecular Biology (14%), Economics, Econometrics and Finance (6%). It does 2.6× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 16 fields, with their numbers
- Health Sciences2873.3%
- Medicine2872.7%
- Health Professions00.6%
- Life Sciences614.5%
- Social Sciences37.2%
- Physical Sciences25.0%
- Engineering12.9%
- Chemistry00.6%
- Materials Science00.6%
- Mathematics00.3%
- Environmental Science00.3%
- Physics and Astronomy00.2%
- Computer Science00.2%
What does MedSIR (Spain) specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.8× the share of its output that it takes of world research.
- MedicineField · 27.9 works3.8×
- Health SciencesDomain · 28.2 works3.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
All 16 fields, with their numbers
- Medicine3.78×28 works
- Economics, Econometrics and Finance2.74×2 works
- Biochemistry, Genetics and Molecular Biology2.54×5 works
- Immunology and Microbiology0.97×0 works
- Chemistry0.39×0 works
- Mathematics0.26×0 works
- Health Professions0.24×0 works
- Engineering0.19×1 works
- Materials Science0.17×0 works
- Psychology0.16×0 works
- Decision Sciences0.15×0 works
- Physics and Astronomy0.09×0 works
- Business, Management and Accounting0.09×0 works
- Environmental Science0.06×0 works
- Social Sciences0.03×0 works
- Computer Science0.02×0 works
- Medicine 3.8×
- Economics, Econometrics and Finance 2.7×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Immunology and Microbiology 1.0×
- Chemistry 0.4×
- Mathematics 0.3×
- Health Professions 0.2×
- Engineering 0.2×
- Materials Science 0.2×
- Psychology 0.2×
- Decision Sciences 0.1×
- Physics and Astronomy 0.1×
- Business, Management and Accounting 0.1×
- Environmental Science 0.1×
- Social Sciences 0.0×
- Computer Science 0.0×
Who are the top researchers at MedSIR (Spain)?
Ranked on the quality score, José Manuel Pérez-García, Miguel Sampayo-Cordero and Daniel Alcalá-López lead among researchers whose main affiliation is MedSIR (Spain).
- 1
José Manuel Pérez-García
Spain · #139,089 worldwide 7.6k citations · 247 works
- 2
Miguel Sampayo-Cordero
Spain · #288,571 worldwide 1.4k citations · 104 works
- 3
Daniel Alcalá-López
Spain · #289,950 worldwide 713 citations · 37 works
- 4
Leonardo Bruno Mina
Spain · #653,550 worldwide 674 citations · 48 works
- 5
Andrea Malfettone
Spain · #1,117,206 worldwide 2.3k citations · 109 works
- 6
Marta Campolier
Spain · #1,174,403 worldwide 158 citations · 20 works
- 7
Patricia Cortez
Spain · #1,729,311 worldwide 336 citations · 17 works
- 8
Sarah Ananda Gomes
Spain · #2,697,135 worldwide 40 citations · 20 works
- 9
Flavia Santos Dumont Sorice
Spain · #2,773,371 worldwide 13 citations · 16 works
- 10
Miguel Sampayo
Spain · #3,532,983 worldwide 189 citations · 28 works
Which keywords describe research at MedSIR (Spain)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Quality of Life, Metastatic Breast Cancer, Clinical Practice Guidelines, Radiotherapy, Survival Analysis and Metastatic.
- Ethical Considerations
- Cognitive Function
- Taxanes
- Financial Toxicity
- Cancer Therapy
- Targeted Therapy
- Clinical Trials
- Psychosocial Interventions
- Health-related Quality of Life
- Prognostic Markers
- Neoadjuvant Therapy
- Immunotherapy
- Cancer Survivorship
- Trastuzumab
- HER2
- EGFR
- Metastatic
- Radiotherapy
- Clinical Practice Guidelines
- Breast Cancer
- Chemotherapy
- Quality of Life
- Metastatic Breast Cancer
- Survival Analysis
- CDK4/6 Inhibitors
- Gene Expression
- Palbociclib
- Anxiety
- Depression
- Molecular Subtypes
- Physical Activity
- Breast Tumours
- Patient-Reported Outcomes
- Treatment Response
- Metastasis
- Biomarkers
- Cost of Care
- Chemotherapy-Induced Peripheral Neuropathy
- Tumor Microenvironment
- End-of-Life
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy7▲ 27×16 topics
- Breast Cancer7▲ 73×9 topics
- Quality of Life6▲ 10×9 topics
- Clinical Practice Guidelines4▲ 20×8 topics
- Metastatic Breast Cancer4▲ 183×2 topics
- Radiotherapy4▲ 27×8 topics
- Survival Analysis3▲ 30×4 topics
- Metastatic3▲ 108×2 topics
- CDK4/6 Inhibitors2▲ 225×1 topic
- EGFR2▲ 204×1 topic
- Gene Expression2▲ 10×4 topics
- HER22▲ 204×1 topic
- Palbociclib2▲ 225×1 topic
- Trastuzumab2▲ 133×2 topics
- Anxiety2▲ 13×2 topics
- Cancer Survivorship2▲ 81×2 topics
- Depression2▲ 7.0×2 topics
- Immunotherapy2▲ 8.6×10 topics
- Molecular Subtypes2▲ 72×3 topics
- Neoadjuvant Therapy2▲ 26×4 topics
- Physical Activity2▲ 13×2 topics
- Prognostic Markers2▲ 57×2 topics
- Breast Tumours2▲ 123×1 topic
- Health-related Quality of Life2▲ 26×2 topics
- Patient-Reported Outcomes2▲ 109×1 topic
- Psychosocial Interventions2▲ 109×1 topic
- Treatment Response2▲ 123×1 topic
- Clinical Trials2▲ 8.4×6 topics
- Metastasis2▲ 17×5 topics
- Targeted Therapy2▲ 25×4 topics
- Biomarkers2▲ 6.5×6 topics
- Cancer Therapy2▲ 8.3×7 topics
- Cost of Care2▲ 154×1 topic
- Financial Toxicity2▲ 154×1 topic
- Chemotherapy-Induced Peripheral Neuropathy2▲ 144×1 topic
- Taxanes2▲ 144×1 topic
- Tumor Microenvironment2▲ 8.6×4 topics
- Cognitive Function1▲ 20×2 topics
- End-of-Life1▲ 38×2 topics
- Ethical Considerations1▲ 10×2 topics
Which research topics does MedSIR (Spain) publish most on?
By volume in 2022-now: Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies and Cancer survivorship and care.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
- 2 HER2/EGFR in Cancer Research Oncology 2 works
- 3 Breast Cancer Treatment Studies Cancer Research 2 works
- 4 Cancer survivorship and care Oncology 2 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 6 Cancer Treatment and Pharmacology Oncology 2 works
- 7 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 9 Lung Cancer Research Studies Oncology 1 works
- 10 Oral health in cancer treatment Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has MedSIR (Spain)'s research output changed?
Output in 2022-2025 was 130% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is MedSIR (Spain) as a percentage of every work published that year, 0.00024% in 2024.
Fractional works of MedSIR (Spain) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Barcelona
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- CERCA Institution
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about MedSIR (Spain). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.